We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Signet Announces the Release of an sAPPbeta Antibody
Product News

Signet Announces the Release of an sAPPbeta Antibody

Signet Announces the Release of an sAPPbeta Antibody
Product News

Signet Announces the Release of an sAPPbeta Antibody


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Signet Announces the Release of an sAPPbeta Antibody "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Signet Laboratories, Inc. has announced the availability of a polyclonal antibody specific for sAPPbeta, a cleavage product of amyloid precursor protein.

"Quantitative analysis of the cleavage products generated during the processing of amyloid precursor protein is critical to the understanding of the pathogenesis of Alzheimer's disease," said Joe Bertelsen, Neuroscience Product Manager, Signet Laboratories, Inc.

"Signet's sAPPbeta specific antibody, the first of its kind commercially available to AD researchers, will serve as a powerful tool in the development of diagnostic and therapeutic strategies for this devastating disease."

Advertisement